Cutera (CUTR) to Release Earnings on Tuesday

Cutera (NASDAQ:CUTR) will issue its quarterly earnings data after the market closes on Tuesday, November 6th. Analysts expect the company to announce earnings of ($0.08) per share for the quarter. Cutera has set its FY18 guidance at $0.50-0.60 EPS.

Cutera (NASDAQ:CUTR) last announced its quarterly earnings results on Tuesday, August 7th. The medical device company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06). The company had revenue of $42.55 million for the quarter, compared to analyst estimates of $41.50 million. Cutera had a return on equity of 10.21% and a net margin of 15.67%. On average, analysts expect Cutera to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of NASDAQ:CUTR opened at $21.26 on Tuesday. The firm has a market cap of $279.23 million, a PE ratio of 27.61 and a beta of 0.31. Cutera has a 52-week low of $19.11 and a 52-week high of $56.05.

In related news, insider James A. Reinstein acquired 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 29th. The stock was acquired at an average cost of $32.02 per share, for a total transaction of $32,020.00. Following the completion of the acquisition, the insider now directly owns 139,907 shares of the company’s stock, valued at approximately $4,479,822.14. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.80% of the company’s stock.

CUTR has been the subject of several research analyst reports. Sidoti set a $50.00 price target on shares of Cutera and gave the stock a “buy” rating in a report on Friday, October 5th. ValuEngine downgraded Cutera from a “buy” rating to a “hold” rating in a report on Wednesday, August 29th. Stephens decreased their price objective on Cutera from $40.00 to $24.94 and set a “sell” rating for the company in a report on Friday, October 5th. Stifel Nicolaus decreased their price objective on Cutera from $55.00 to $45.00 and set a “hold” rating for the company in a report on Wednesday, August 8th. Finally, Zacks Investment Research downgraded Cutera from a “hold” rating to a “sell” rating in a report on Monday, August 13th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $39.24.

Cutera Company Profile

Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.

Recommended Story: Do You Need a Fiduciary?

Earnings History for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with's FREE daily email newsletter.

Leave a Reply